The Library

PRP is not one product. Platelet dose, leukocyte profile, red cell contamination, and pre-activation change what reaches the joint, and what the studies show.

In a 2026 survey of 357 orthopedic patients, 66.9% believed orthobiologics could treat cartilage injuries. How we decide when an injection does not fit.

A data review before the session, a 60-minute physician-led root-cause discussion, and a written terrain roadmap naming the bottlenecks and the sequence.

PRP results for tennis elbow depend on when you measure and who was enrolled. The trial-by-trial eligibility and exclusion criteria, stated plainly.

Level I evidence supports PRP in rotator cuff tears and discourages it in Achilles and patellar tears. Why the injection target decides what the data mean.

In a MOST analysis of 395 knees, 66% of bone marrow lesions changed size over 30 months and half resolved. How to read the finding on your report.

SI joint pain drives 15-25% of back pain, yet only 45% of fusion patients had a diagnostic injection first. Why confirmation comes before PRP or BMAC.

A staged return-to-lifting plan after PRP, BMAC or Lipogems: readiness checks, three loading stages, knee and disc modifications, and the signs that mean stop.

Why there is no single recovery schedule after PRP, BMAC or Lipogems, what the phases actually are, and the survey data on what patients wrongly expect.

How much protein, distributed how, and how often to lift — the sourced numbers behind protecting muscle after 30, and what to do when joint pain is the real limit.

Heel pain that did not respond to first-line care: where PRP, BMAC and Lipogems actually sit in the published treatment sequence, and what has to be confirmed first.

Most studies report around 75% success with non-operative treatment of rotator cuff tears. What that aggregate means, and where orthobiologics genuinely enter.

The three are not interchangeable. The selection follows the tissue target, and one randomized knee trial compared BMAC, PRP, and hyaluronic acid over 12 months.

Osteoporosis affects 12.6% of US adults aged 50 and over, and low bone mass a further 43.1%. What that means when you are being evaluated for a degenerating joint.

Nicotine reduced vascularity and left healed tendon 44.7% weaker in a rat model. In human bone-forming cells it was whole smoke, not nicotine, that did the damage.

How micro-fragmented adipose tissue is processed, what the published cluster sizes are, and what it is not claimed to do for an arthritic knee.

In knee osteoarthritis, leukocyte-rich and leukocyte-poor PRP have not separated on pain or function, but local reactions differ. What the trial evidence says.

Your Kellgren-Lawrence grade describes what a knee X-ray shows, not how much pain you feel. What grades 0 to 4 mean, and how reliable the number really is.

PRP placed into subchondral bone, not just the joint space. What the randomized trials on both sides show, who they excluded, and why it is a bridge and not cartilage repair.

Orthobiologics are made from your own blood, marrow, or fat. How collection, timing, sterility, and injection target change what ends up in the syringe.

Tendon pathology is present in 88% to 98% of lateral hip pain and isolated bursitis in about 2%. What that changes about which orthobiologic is worth discussing.

A 2026 meta-analysis of 821 adults on obesity-dose GLP-1 receptor agonists reported a mean 1.74 kg fall in absolute lean mass. What that means for your plan.

Facet joints are the pain source in 15% to 41% of patients with chronic low back pain. What confirming that changes, and where orthobiologics honestly fit.

Cervical facet pain: one randomized PRP trial, three series, and the metabolically complex patients every one of them screened out. St. Louis.

BMAC is an autologous concentrate, and it does not regrow or regenerate cartilage. What a 2025 narrative review establishes about knee osteoarthritis, and what it does not.

In 90 patients with grade 3-4 knee osteoarthritis on arthroplasty waiting lists, two PRP injections beat steroid and NSAID at six months. A bridge, not a swap.

Across 9 trials of insertional Achilles tendinopathy, overall certainty for non-surgical care was very low. What that means before you consider an injection.

You asked about platelet-rich plasma. About bone marrow concentrate. About real regenerative treatment for a chronic, degenerative problem. And your insurance company gave you the answer it always gives: experimental, investigational, denied. What that denial does not tell…

If you have stood on the vibration plate at your gym hoping it would do something for your knees, your back, or your hips — and stepped off with nothing to show for it — the machine was…

If you have spent several hundred dollars on a red light panel hoping it would help your back, your hip, or an arthritic joint — and it has not — you were not sold a fraud. You were…

If you have been told your only remaining option is surgery, there is a technology worth understanding before you accept that framing. First, a clarification, because the word “shockwave” has been diluted by marketing. This is not the…

The prevailing model treats your spine as a mechanical structure — a stack of parts, one of which has worn out. That framing determines everything that follows: image it, find the worn part, numb it or remove it.…

There is a fire alarm going off in the building, and the standard response has been to argue with the alarm. Turn it down. Change the batteries. Put tape over the speaker. What almost never happens is someone…